NORDIC BIOTECH GENERAL PARTNER II ApS: Financial statements 2013
CVR: 29148805
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
NORDIC BIOTECH GENERAL PARTNER II ApS (CVR 29148805) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -5,421 and a net result of DKK -5,422 compared with DKK -4,943 the year before. Equity in the 2013 report amounted to DKK 118,587. The solvency ratio was 87.1%.
- Gross Profit
- DKK -5,421
- Profit/Loss
- DKK -5,422
- Equity
- DKK 118,587
- Total Assets
- DKK 136,087
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of November 22, 2013, Jakob Mosegaard Larsen is registered as liquidator of NORDIC BIOTECH GENERAL PARTNER II ApS.
As of November 22, 2013, Claus Tycho Bræstrup has stepped down as direktion of NORDIC BIOTECH GENERAL PARTNER II ApS.
As of November 22, 2013, Florian Schønharting has stepped down as direktion of NORDIC BIOTECH GENERAL PARTNER II ApS.
On November 22, 2013, NORDIC BIOTECH GENERAL PARTNER II ApS entered liquidation.
NORDIC BIOTECH GENERAL PARTNER II ApS has published its annual report for 2012. The net result was DKK -4,943.
About NORDIC BIOTECH GENERAL PARTNER II ApS
NORDIC BIOTECH GENERAL PARTNER II ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company has been dissolved on 28 May 2015. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2013, the company reported a gross profit of DKK -5,421 and a net result of DKK -5,422 compared with DKK -4,943 the year before. Equity in the 2013 report amounted to DKK 118,587.
